GlassScriptPhysician profile
Joshua Jones
NPI 1063831675
$2,464.40
in general payments reported to CMS, 2019-2025
16 companies · $539 in 2025
The $539 reported for 2025 was more than what 80% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $175 · 2020: $69.16 · 2021: $229 · 2022: $330 · 2023: $567 · 2024: $555 · 2025: $539.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,661.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,661.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $827.96 | 2022-2025 | |
| Alcon Vision LLC | $531.52 | 2019-2025 | Argos, Clareon, Simbrinza |
| Bausch & Lomb Americas INC. | $340.21 | 2022-2025 | Miebo, Xiidra, Vyzulta |
| Tarsus Pharmaceuticals, INC. | $230.30 | 2024-2025 | Xdemvy |
| Allergan, INC. | $108.49 | 2019-2021 | |
| Sight Sciences, INC. | $103.85 | 2021-2024 | Omni Surgical System |
| Aerie Pharmaceuticals, INC. | $83.77 | 2019-2021 | |
| Astellas Pharma US INC | $80.40 | 2024-2025 | Izervay |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $30.36 | 2021 | |
| Harrow Eye, LLC | $21.12 | 2024 | Vevye |
| Rxsight INC | $20.17 | 2025 | Rxsight Light Delivery Device (Ldd), Rxsight Contact Lens, Rxsight Injector Handpiece |
| Kala Pharmaceuticals, INC. | $18.73 | 2019 | |
| Johnson & Johnson Surgical Vision, INC. | $18.07 | 2024 | Tecnis Iol |
| Shire North American Group INC | $17.56 | 2019 | |
| Eyevance Pharmaceuticals LLC | $16.34 | 2020 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Optos, INC. | $15.55 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joshua Jones listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.